spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  corticotropin 

 HSMN NewsFeed - 29 Apr 2020
ANI Receives Refusal to File Letter from FDA for Cortrophin(R) Gel
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Apr 2020
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin(R) Gel 80 U/mL
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 May 2019
Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar(R) Gel
Biopharmaceuticals Reimbursement Litigation
 HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2018
Eiger BioPharmaceuticals Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2017
Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jun 2013
Questcor Pharmaceuticals Acquires Rights to Synacthen(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 22 Nov 2010
New Data on H.P. Acthar(R) Gel in the Treatment of Nephrotic Syndrome Presented at the American Society of Nephrology 43rd Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 22 Nov 2010
Interim Results From Independent Study of H.P. Acthar(R) Gel in Patients With Advanced Diabetic Nephropathy Presented at American Society of Nephrology 43rd Annual Meeting
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 3 Nov 2010
Questcor Pharmaceuticals Launches Acthar for the Treatment of Infantile Spasms
Biopharmaceuticals
 HSMN NewsFeed - 15 Oct 2010
FDA Approves H.P. Acthar(R) Gel for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Dec 2009
FDA Accepts for Review Questcor's Filing of Its Supplemental New Drug Application for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Dec 2009
Louis Silverman Appointed to Questcor Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2008
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2007
Questcor Appoints Don M. Bailey as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2007
Questcor Appoints Stephen Farrell to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2007
Questcor Announces Departure of CEO James Fares
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2007
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 27 Sep 2006
Questcor Elects David Young, Pharm.D., Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2006
Questcor Files sNDA for Treatment of Infantile Spasms with H.P. Acthar(R) Gel
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Jun 2006
Questcor Announces the Commercial Availability of Doral(R) and Outlines Future Development Pipeline
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2006
Questcor Announces the Acquisition of Doral(R) (quazepam)
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 8 Mar 2006
Neurocrine Biosciences Announces Results of The Phase II Study in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Feb 2006
Celtic Pharma and Neurobiological Technologies Announce Initiation of Second Pivotal Phase III Clinical Trial for XERECEPT(R), a Therapy for Peritumoral Brain Edema
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
corticotropin
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.